Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2026
HILLSIDE, NJ / ACCESS Newswire / September 25, 2026 / (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2026.Revenue for the quarter ended June 30, 2026 was $9.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo